eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Pca, |
LNCaP |
|
|
|
- |
in-vitro, |
Pca, |
DU145 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
TumCP↓, P53↑, P21↑, BAX↑, PSA↓, AR↓, NF-kB↓, Proteasome↓, TumVol↓, eff∅,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death(tgid=5) ⓘ
BAX↑, 1, Proteasome↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↑, 1,
Migration(tgid=13) ⓘ
TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1, PSA↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
AR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff∅, 1,
Clinical Biomarkers(tgid=22) ⓘ
AR↓, 1, PSA↓, 1,
Functional Outcomes(tgid=23) ⓘ
TumVol↓, 1,
Total Targets: 12
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:961 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page